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Well known medical herbal compounds including apigenin, daidzein, phyllanthin and 
tyramine were assessed against Trypanosoma and Leishmania protozoans. Two strains of the 
bloodstream forms of Trypanosoma brucei: s427-WT and TbAT1-B48, and Leishmania 
major promastigotes and Leishmania mexicana were utilised.. Among selected natural 
compounds, apigenin and daidzein displayed moderate activity against African trypanosomes 
with EC50 16 µM for wild-type sensitive control strain. Tyramine was not found very active 
for trypanosomes strains while all compounds were found trivial for the inhibition of 
Leishmania mexicana strains. 
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1. INTRODUCTION 
A leading cause of numerous tropical diseases is protozoan parasites that are members of the 
Trypanosomatidae family. Approximately 65 million people of African countries are at risk 
to become infected with sleeping sickness which can be lethal if left untreated (WHO Report, 
2017). Sleeping sickness is transmitted by the tsetse fly and caused by the Trypanosoma 
brucei subspecies such as T. b. gambiense and T. b. rhodesiense (Lindner et al., 2010). In 
2009, after continued control efforts, the number of cases reported dropped below 10 000 
(9878) for the first time in 50 years. This turned down in number of cases has sustained with 
2804 new cases reported in 2015, the lowest level since the start of systematic global data-
collection 76 years ago (WHO, 2017).  
Leishmaniasis refers to a collection of chronic diseases caused by protozoa of the genus 
Leishmania and naturally transmitted by sand flies (Alvar et al., 2012; Stockdale et al., 
2013). Pentavalent antimonials and pentamidine used for the treatment of leishmaniasis, are 
toxic or have severe side effects, such as renal, cardiac and neural toxicity, risk of diabetes 
and shock (Tiuman et al., 2011). No vaccine is still available for human leishmaniasis while 
the drugs used against the parasite are very toxic and patients are also frequently 
unresponsive to treatment (Koff et al., 1994; Kumar et al., 2014; Tiuman et al., 2011). 
Leishmania (L.) mexicana infects many hosts (Berzunza et al., 2015) and has been detected 
in an assortment of wild and domestic mammals, while humans are opportunistic hosts 
(Courtenay et al., 2017; Martina et al., 2017). Cutaneous leishmaniasis caused by Leishmania 
(L.) mexicana was first depicted in chicle collectors of the Yucatan peninsula in 1912 by 
Seidelin, therefore its name is “Chiclero´s Ulcer” (Seidelin, 1912).  
The drugs currently being used for the treatment display a high level toxicity, inadequate 
efficacy and require a long period of treatment (Kerboeuf et al., 2008). Moreover, it has been 
reported that there is development of drug resistance by the parasites ( Croft et al., 2005; 
Kerboeuf et al., 2008; Paes et al., 2011). Thus, it is incumbent to explore new drugs or 
compounds that might be allied with the conventional treatment. Natural sources such as 
plants, algae and micro-organisms constitute as an important source of alternative drugs 
(Medeiros et al., 2011; Rondon et al., 2012; Wink, 2012; Gamboa-Leon et al., 2014; Sifaoui 
et al., 2014). It has been estimated that there are about 250,000 medical plant species in the 
world but on the other hand, the therapeutic potential of only about 6% of them has been 
biologically evaluated. Furthermore, only approximately 0.75% of identified medical herbal 
compounds have been studied in clinical trials (Jameel et al., 2014). The foremost virtues of 
herbal medicine include their low cost, the low prevalence of severe adverse effects and 
superior efficacy. 
In the current study we selected some well-known medical herbal compounds apigenin, 
daidzein, phyllanthin and tyramine. Because of the reported antileishmanial and various 
biological activities of these natural compounds (Wong et al., 2009; Ilangkovan et al., 2016), 
now we decided to further investigate their activity against various Trypanosoma and 
Leishmania strains including the well-characterised and multi-drug resistant Trypanosoma 
brucei clonal line B48. The clonal line B48 is highly resistant to the two main classes of 
trypanocides, the melaminophenyl arsenicals and the diamidines, due to the loss the 
TbAT1/P2 and HAPT1 drug transporters (Bridges et al., 2007). 
2. MATERIALS AND METHODS 
 
2.1 Materials 
All tested pure compounds including apigenin, daidzein, phyllanthin and tyramine were 
purchased from Sigma (Steinheim, Germany). Stock solution in 100% DMSO for each 
compound was prepared and for the concentrations used in assay, the calculated amount of 
stock solution was taken and diluted with complete medium, ensuring that the final DMSO 
concentration did not exceed 1% in the final conditions. EC50 values were obtained using the 
Alamar blue assay and are given as averages in µM (±SEM), of 3 independent evaluations. 
2.2 Cell culture 
2.2.1 Trypanosoma brucei bloodstream forms (BSF) in-vitro 
In this research, two strains of the bloodstream forms of Trypanosoma brucei were utilised. 
The first was the wild type strain of Trypanosoma brucei brucei (s427-WT) and the other was 
TbAT1-B48 that was acquired from the clone TbAT1-KO (Matovu et al., 2003) by exposure 
to pentamidine thus causing more resistance to pentamidine, diminazene as well as 
melaminophenyl arsenicals. Consequently, these cells have neither TbAT1/P2 transporter nor 
the high affinity-pentamidine transporter genes (Bridges et al., 2007;Munday et al., 2014). 
Both strains were cultured in HMI-9 medium (pH 7.4) supplemented with 10%  Fetal Calf 
Serum and 14 µl/ Litre of 13.4M β-mercaptoethanol, (FCS) as described by Hirumi and 
Hirumi(Hirumi et al., 1989). The medium was sterilized by filtration (0.22 µm, Millipore) 
inside a flow cabinet using. The T. b. brucei cultures were incubated at 37ºC and 5% CO2 and 
passaged invented flasks three times a week. All  
     2.1.2. Leishmania major Promastigotes and Leishmania mexicana 
Leishmania major strain Friedlin (LmjF) and strains of Leishmania mexicana 
(MNYC/BZ/62/M379) were propagated in essential medium (HOMEM) with a PH value of 
7.4 and 10% Fetal Calf Serum (FCS) heat-inactivation using plastic flasks at the temperature 
of 25ºC. The resultant cultures were then passed through fresh medium thrice per week. 
2.3 Alamar blue assay to determine the sensitivity totest compounds 
Resazurin sodium salt (Alamar Blue) is commonly used as a cell metabolic function 
indicator. It is a non-fluorescent, blue dye that is mixed with cell cultures containing various 
drug concentrations, in order to determine the sensitivity of African trypanosomes or 
Leishmania culturesto the test compounds in vitro (Fumarola et al., 2004;Raz et al., 1997). In 
case there are no toxic effects caused by the drug, the color of the living cells changes to red 
and fluorescent from blue. Preparation of Alamar Blue involves the dissolution of 12.5 
milligrams of Resazurin sodium salt (Sigma) in 100 mL of phosphate-buffered saline (PBS) 
of pH 7.4, which was then filter-sterilized and stored in the dark at 4ºC.  
2.3.1 Drug sensitivity using Alamar Blue assay in T. b. brucei BSF 
For each test compound a solution of 200 µM in HMI-9 medium + 10%FCS is prepared 
using a 20 mM stock solution in DMSO; 200 μL of this is added to a first well of a 96-well 
plate. Of this, 100 μL is transferred to the next well, containing 100 μL of the same medium, 
achieving a 1:1 dilution, initiating a doubling dilution series across 2 rows of the plate; each 
experiment was positively controlled using pentamidine and the final well for each compound 
received 100 microliters of HMI-9 medium as negative control. To each well, 100 μL of a 
suspension of 2 × 105 cells/ml was added, amounting to 1×105 cells/ml as the final cell 
density. The plate is then incubatedfor 48 hours at 37 ºC/5% CO2 after which 20 µL of the 
Alamar Blue solution is added, followed by another incubation of the plate for 24 hours. A 
fluorimeter (FluoStar Optima) is used to read the fluorescence of the plate at the wavelengths 
of 590 nm for emission and 530 nm for excitation and the data are analysed using the 
GraphPad Prism5 software package, fitting the fluorescence to a sigmoid curve with variable 
slope to determine the EC50value. 
3. RESULTS AND DISCUSSION 
In the present study, we demonstrated the effect of natural compounds on the growth of 
promastigotes of L. major, L. mexican and different strains of Trypanosoma brucei brucei in 
vitro. The antitrypanosomal and leishmanicidal activities of natural compounds are 
summarized in Table 1. 
3.1 Apigenin and daidzein 
Apigenin belongs to the flavone subclass of flavonoids (Kim, 2003) and is abundant in a 
variety of fruits, vegetables, and herbs. It frequently exists in food sources as a glycoside, 
which improves its solubility and bioavailability (Ross et al., 2002). An array of biological 
activities has been reported for apigenin, including the ability to inhibit proliferation and 
induce apoptosis in several cancer cell lines, as well as a capacity to inhibit angiogenesis 
(Zhou et al., 2017). Daidzein is a naturally occurring isoflavonic phytoestrogen, belonging to 
the non-steroidal estrogens, and is mainly derived from leguminous plants such assoybean 
and mung bean. Traditional Chinese medicine Gegen contains Daidzein as its main bioactive 
component is used often in the treatment of fever, acute dysentery, diarrhoea, diabetes, 
cardiac dysfunctions, liver injury etc (Knight et al., 1996). 
The apigenin dimer amen to flavone, the only bioflavonoid investigated here, also showed 
some antileishmanial effect (IC50, 6.0 µg/ml) (Tasdemir et al., 2006). In the current 
evaluation two different types of Ttrypanosoma brucei brucei were used including wild type 
(WT) and the highly resistant Trypanosoma brucei clonal line B48. Regarding possible 
mechanism of action, apigenin and daidzein showed highly similar effects on both strains, as 
presented in Table 1. EC50 values for both compounds for these compounds were found 
between 13.4 to 16.9 µM and the results indicate that the TbAT1/P2 and HAPT1 drug 
transporters are not utilized by either compound. Considering the virtually identical 
antitrypanosomal effects, the position of the 4-hydroxybenzene moiety on the main 
pharmacophore did not seem to be critical. 
 
 
Table 1: Effect of selected natural compounds on Trypanosoma brucei brucei and 














1. Apigenin 16.9±1.2 13.4±0.6 0.79 70.2±10.7 >100 
2. Daidzein 16.6±1.8 16.4±1.0 0.99 >100 >100 
3. Phyllanthin 66.6±2.3 64.5±3.6 0.97 >100 >100 
4. Tyramine >100 >100 - >100 >100 
        Pentamidine 0.005±0.00 0.37±0.01 74.0 4.3±0.2 1.2±0.1 
All EC50 values were obtained using the Alamar blue assay and are given as averages in µM (±SEM), of 3 
independent evaluations. WT = wild-type sensitive control strain; B48 is a multi-drug resistant clone; Resistance 
Factor = EC50 (resistant clone)/EC50 (WT). 
 
On the other hand, only apigenin showed some effect on Leishmania major promastigotes 
and there where as at concentrations up to 100 μM no antileishmanial activity was observed 




Phyllanthin, found in many Phyllanthus species, has various biochemical and 
pharmacological properties especially hepatoprotective effects. Indeed, we have previously 
reported that among the bioactive constituents of Phyllanthus amarus Schum and Thonn 
(Euphorbiaceae), phyllanthin has been well examined for its biochemical and 
pharmacological properties, and particularly for its protective effects on the liver (Ilangkovan 
et al., 2016). Phyllanthin has also been much investigated for its antitumor effects on various 
cancer cell lines (Krithika et al., 2011). In the present research, phyllanthin was also 
examined for effects on Trypanosoma brucei brucei and Leishmania mexicana. Results are 
shown in table 1 and it was observed that this natural compound has similar if moderate 
effect on both strains of Trypanosoma brucei brucei, showing that phyllanthin is also not 
using specified drug transporters and that compounds of this class would not display cross-
resistance with diamidines and melaminophenyl arsenical drugs. 
3.3 Tyramine 
Tyramine is a substance generally found in nature, as it can be formed from the amino acid 
tyrosine by the action of the ubiquitous enzyme aromatic amino acid decarboxylase. 
Tyramine is a vasoactive amine that promotes blood pressure elevation, resulting in pain. 
Tyramine leads to cerebral vasoconstriction and subsequent rebound vasodilatation that 
causes a migraine attack in susceptible persons (Costa et al., 2003). This compound was not 
found active against Trypanosoma and Leishmania strains and showed >100 µM EC50. 
4. Conclusion 
In this study, some new natural compounds were selected for determination of their activity 
against various Trypanosoma strains and Leishmania species including multi-drug resistant 
Trypanosoma brucei clonal line B48.The results obtained herein revealed that the two related 
natural compounds, apigenin and daidzein displayed moderate activity against African 
trypanosomes and are not cross-resistant with current dugs for this infection. A systematic 
investigation of this scaffold is likely to result in the identification of compounds with 
substantially improved activity against kinetoplastid parasites, particularly the African 
trypanosomes, which are not only the etiological agents of human sleeping sickness but also 
of the livestock disease nagana, which causes agricultural losses in Africa that measure in the 
billions of dollar (Giordani et al., 2016). For both conditions, new drugs are urgently needed. 
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